These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 1551042)

  • 21. Exploring Anabolic-Androgenic Steroid Use and Teen Dating Violence Among Adolescent Males.
    Ganson KT; Cadet TJ
    Subst Use Misuse; 2019; 54(5):779-786. PubMed ID: 30572768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anabolic-androgenic steroids and the risk of imprisonment.
    Christoffersen T; Andersen JT; Dalhoff KP; Horwitz H
    Drug Alcohol Depend; 2019 Oct; 203():92-97. PubMed ID: 31421475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anabolic androgenic steroids, antisocial personality traits, aggression and violence.
    Hauger LE; Havnes IA; Jørstad ML; Bjørnebekk A
    Drug Alcohol Depend; 2021 Apr; 221():108604. PubMed ID: 33621808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disorder of hypothalamic-pituitary-gonadal axis induced by abusing of anabolic-androgenic steroids for short time: A case report.
    Vilar Neto JO; da Silva CA; Lima AB; Caminha JSR; Pinto DV; Alves FR; Araújo JS; Daher EF
    Andrologia; 2018 Nov; 50(9):e13107. PubMed ID: 30039560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrasexual competition as a potential influence on anabolic-androgenic steroid use initiation.
    Harris M; Dunn M; Alwyn T
    J Health Psychol; 2019 Aug; 24(9):1210-1220. PubMed ID: 28810407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes.
    Pope HG; Katz DL
    Arch Gen Psychiatry; 1994 May; 51(5):375-82. PubMed ID: 8179461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study.
    Grant B; Campbell J; Pradeep A; Burns AD; Bassett P; Abbara A; Saket P; Minhas S; Dhillo WS; McVeigh J; Bhasin S; Jayasena CN
    Eur J Endocrinol; 2023 Dec; 189(6):601-610. PubMed ID: 38102386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgenic-anabolic steroids: the new insidious killer leading to heart failure.
    Polito MV; Dellegrottaglie S; Matturro R; Bonadies D; DE Rosa R; Galasso G
    Minerva Cardioangiol; 2017 Dec; 65(6):663-666. PubMed ID: 28971665
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatotoxic effects of the anabolic/androgenic steroids.
    Ishak KG; Zimmerman HJ
    Semin Liver Dis; 1987 Aug; 7(3):230-6. PubMed ID: 3317860
    [No Abstract]   [Full Text] [Related]  

  • 30. [The frequency of formation of a motivated refusal to take androgenic anabolic steroids by men with recreational activity].
    Lykhonosov MP; Babenko AY; Makarin VA; Fedotov YN
    Probl Endokrinol (Mosk); 2019 Nov; 65(5):341-350. PubMed ID: 32202738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review.
    Piacentino D; Kotzalidis GD; Del Casale A; Aromatario MR; Pomara C; Girardi P; Sani G
    Curr Neuropharmacol; 2015 Jan; 13(1):101-21. PubMed ID: 26074746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anabolic Androgenic Steroid (AAS) related deaths: autoptic, histopathological and toxicological findings.
    Frati P; Busardò FP; Cipolloni L; Dominicis ED; Fineschi V
    Curr Neuropharmacol; 2015 Jan; 13(1):146-59. PubMed ID: 26074749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abuse of anabolic androgenic steroids and related substances in sport and exercise.
    Bahrke MS; Yesalis CE
    Curr Opin Pharmacol; 2004 Dec; 4(6):614-20. PubMed ID: 15525553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Availability and Acquisition of Illicit Anabolic Androgenic Steroids and Testosterone Preparations on the Internet.
    McBride JA; Carson CC; Coward RM
    Am J Mens Health; 2018 Sep; 12(5):1352-1357. PubMed ID: 27170675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired cardiac structure and systolic function in athletes using supra-physiological doses of anabolic androgenic steroids.
    Hammoud S; van den Bemt BJF; Jaber A; Kurdi M
    J Sci Med Sport; 2023 Oct; 26(10):514-521. PubMed ID: 37758530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outpatient clinic for users of anabolic androgenic steroids: an overview.
    Smit DL; de Ronde W
    Neth J Med; 2018 May; 76(4):167. PubMed ID: 29845939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anabolic androgenic steroid dependence is associated with impaired emotion recognition.
    Hauger LE; Sagoe D; Vaskinn A; Arnevik EA; Leknes S; Jørstad ML; Bjørnebekk A
    Psychopharmacology (Berl); 2019 Sep; 236(9):2667-2676. PubMed ID: 30941469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interdisciplinary and Psychiatric Treatment of Anabolic Androgenic Steroids Users].
    Butzke I; Iff S; Zitzmann M; Quednow BB; Claussen MC
    Praxis (Bern 1994); 2022 Apr; 111(6):339-344. PubMed ID: 35473320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use, Misuse and Abuse of Testosterone and Other Androgens.
    Linhares BL; Miranda EP; Cintra AR; Reges R; Torres LO
    Sex Med Rev; 2022 Oct; 10(4):583-595. PubMed ID: 34887237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse health effects of anabolic-androgenic steroids.
    van Amsterdam J; Opperhuizen A; Hartgens F
    Regul Toxicol Pharmacol; 2010 Jun; 57(1):117-23. PubMed ID: 20153798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.